Endothelial progenitor cells in diabetes mellitus

Area of Science:

• Cardiovascular Science
• Endocrinology
• Regenerative Medicine

Background:

• Diabetes mellitus significantly elevates cardiovascular disease risk by damaging the vascular endothelium.
• Endothelial progenitor cells (EPCs), derived from bone marrow, are vital for repairing damaged endothelium and forming new blood vessels (postnatal vasculogenesis).
• Reduced and impaired EPC function are characteristic of both type 1 and type 2 diabetes.

Purpose of the Study:

• To review the role of endothelial progenitor cells (EPCs) in the context of diabetic cardiovascular complications.
• To examine how alterations in EPCs contribute to macrovascular and microvascular complications of diabetes.
• To highlight the functional significance of EPCs in disease progression and their potential as therapeutic targets.

Main Methods:

• This is a review article, synthesizing existing research on EPCs in diabetes.
• Literature search focused on studies investigating EPCs, diabetes mellitus, and cardiovascular outcomes.
• Analysis of the mechanisms underlying EPC dysfunction and its impact on endothelial homeostasis.

Main Results:

• Consistent evidence shows a reduction and impairment of EPCs in diabetic patients.
• EPC alterations are linked to both macrovascular (e.g., atherosclerosis) and microvascular (e.g., retinopathy, nephropathy) complications.
• The precise mechanisms by which EPCs protect the cardiovascular system in diabetes are still under investigation.

Conclusions:

• Alterations in endothelial progenitor cells (EPCs) play a significant role in the pathogenesis of diabetic cardiovascular complications.
• EPC dysfunction is a key feature of diabetes, contributing to disease progression.
• Targeting EPCs presents a promising therapeutic avenue for managing diabetic vascular complications.